Bank of New York Mellon’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-5,965,338
Closed -$592M – 4325
2019
Q3
$592M Sell
5,965,338
-14,291
-0.2% -$1.36M 0.16% 119
2019
Q2
$553M Sell
5,979,629
-109,540
-2% -$10.4M 0.15% 127
2019
Q1
$574M Sell
6,089,169
-339,140
-5% -$29.7M 0.16% 122
2018
Q4
$412M Buy
6,428,309
+161,938
+3% +$12M 0.13% 148
2018
Q3
$561M Sell
6,266,371
-267,544
-4% -$23.6M 0.14% 130
2018
Q2
$519M Sell
6,533,915
-487,641
-7% -$40.5M 0.14% 140
2018
Q1
$626M Sell
7,021,556
-1,771,433
-20% -$170M 0.17% 113
2017
Q4
$918M Sell
8,792,989
-715,787
-8% -$80.8M 0.24% 78
2017
Q3
$1.39B Sell
9,508,776
-142,020
-1% -$19.3M 0.38% 53
2017
Q2
$1.25B Sell
9,650,796
-437,677
-4% -$53.6M 0.35% 58
2017
Q1
$1.26B Buy
10,088,473
+472,067
+5% +$56.5M 0.35% 57
2016
Q4
$1.11B Buy
9,616,406
+155,475
+2% +$17.3M 0.32% 65
2016
Q3
$989M Buy
9,460,931
+1,567,515
+20% +$170M 0.29% 71
2016
Q2
$779M Sell
7,893,416
-88,556
-1% -$9.16M 0.24% 86
2016
Q1
$799M Sell
7,981,972
-841,275
-10% -$86.6M 0.24% 85
2015
Q4
$1.06B Sell
8,823,247
-439,768
-5% -$50.9M 0.32% 68
2015
Q3
$1B Sell
9,263,015
-602,643
-6% -$74.8M 0.31% 66
2015
Q2
$1.14B Sell
9,865,658
-1,539,630
-13% -$176M 0.31% 66
2015
Q1
$1.32B Sell
11,405,288
-482,839
-4% -$57.7M 0.34% 63
2014
Q4
$1.33B Buy
11,888,127
+862,028
+8% +$90.9M 0.35% 59
2014
Q3
$1.05B Buy
11,026,099
+616,711
+6% +$55.7M 0.28% 73
2014
Q2
$894M Sell
10,409,388
-163,804
-2% -$12.5M 0.24% 85
2014
Q1
$738M Sell
10,573,192
-1,428,308
-12% -$113M 0.2% 98
2013
Q4
$1.01B Sell
12,001,500
-369,422
-3% -$29.2M 0.28% 72
2013
Q3
$953M Buy
12,370,922
+409,918
+3% +$28.7M 0.28% 71
2013
Q2
$700M Buy
+11,961,004
New +$720M 0.22% 91

Other funds holding CELG

Bank of New York Mellon's CELG Position: Q4 2019 in Review

Bank of New York Mellon sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,965,338 shares — an estimated $592M sold.

Bank of New York Mellon first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.39B in Q3 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bank of New York Mellon reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 5,965,338 Celgene Corp shares in Q4 2019, an estimated $592M.
  • Bank of New York Mellon first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Bank of New York Mellon's Celgene Corp position peaked at $1.39B in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.